Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
American Health & Drug Benefits|July 4, 2014
The economic burden of fragile x syndrome: healthcare resource utilization in the United StatesPatricia Sacco, Gorana Capkun-Niggli, Xin Zhang, et al.Clinical Trials (London, England)|February 17, 2010
Summarizing historical information on controls in clinical trialsBeat Neuenschwander, Gorana Capkun-Niggli, Michael Branson, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 1, 2012
Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysisShannon Cope, Matthias Kraemer, Jie Zhang, et al.International Journal of Chronic Obstructive Pulmonary Disease|June 24, 2011
Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysisShannon Cope, Gorana Capkun-Niggli, Rupert Gale, et al.Respiratory Research|April 12, 2011
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic reviewMarie Westwood, Jean Bourbeau, Paul W Jones, et al.Contemporary Clinical Trials|July 19, 2011
Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPDDonald E Stull, Ingela Wiklund, Rupert Gale, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparisonShannon Cope, Gorana Capkun-Niggli, Rupert Gale, et al.Respiratory Research|October 8, 2013
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysisShannon Cope, James F Donohue, Jeroen P Jansen, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2012
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosisKavi J Littlewood, Kyoko Higashi, Jeroen P Jansen, et al.Pageof 1